JP2022532108A5 - - Google Patents

Info

Publication number
JP2022532108A5
JP2022532108A5 JP2021566070A JP2021566070A JP2022532108A5 JP 2022532108 A5 JP2022532108 A5 JP 2022532108A5 JP 2021566070 A JP2021566070 A JP 2021566070A JP 2021566070 A JP2021566070 A JP 2021566070A JP 2022532108 A5 JP2022532108 A5 JP 2022532108A5
Authority
JP
Japan
Prior art keywords
chromosomal
interactions
dlbcl
markers
samples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021566070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022532108A (ja
JP7617029B2 (ja
Filing date
Publication date
Priority claimed from GBGB1906487.2A external-priority patent/GB201906487D0/en
Priority claimed from GB201914729A external-priority patent/GB201914729D0/en
Priority claimed from GBGB2006286.5A external-priority patent/GB202006286D0/en
Application filed filed Critical
Priority claimed from PCT/GB2020/051105 external-priority patent/WO2020225551A1/en
Publication of JP2022532108A publication Critical patent/JP2022532108A/ja
Publication of JP2022532108A5 publication Critical patent/JP2022532108A5/ja
Priority to JP2024211835A priority Critical patent/JP2025032205A/ja
Application granted granted Critical
Publication of JP7617029B2 publication Critical patent/JP7617029B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021566070A 2019-05-08 2020-05-06 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー Active JP7617029B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024211835A JP2025032205A (ja) 2019-05-08 2024-12-04 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1906487.2A GB201906487D0 (en) 2019-05-08 2019-05-08 DNA Marker
GB1906487.2 2019-05-08
GB201914729A GB201914729D0 (en) 2019-10-11 2019-10-11 DNA marker
GB1914729.7 2019-10-11
GB2006286.5 2020-04-29
GBGB2006286.5A GB202006286D0 (en) 2020-04-29 2020-04-29 DNA marker
PCT/GB2020/051105 WO2020225551A1 (en) 2019-05-08 2020-05-06 Chromosome conformation markers of prostate cancer and lymphoma

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024211835A Division JP2025032205A (ja) 2019-05-08 2024-12-04 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー

Publications (3)

Publication Number Publication Date
JP2022532108A JP2022532108A (ja) 2022-07-13
JP2022532108A5 true JP2022532108A5 (https=) 2023-05-16
JP7617029B2 JP7617029B2 (ja) 2025-01-17

Family

ID=70775424

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021566070A Active JP7617029B2 (ja) 2019-05-08 2020-05-06 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー
JP2024211835A Pending JP2025032205A (ja) 2019-05-08 2024-12-04 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024211835A Pending JP2025032205A (ja) 2019-05-08 2024-12-04 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー

Country Status (14)

Country Link
US (1) US20230049379A1 (https=)
EP (1) EP3966350A1 (https=)
JP (2) JP7617029B2 (https=)
KR (1) KR20220007132A (https=)
CN (2) CN114008218B (https=)
AU (3) AU2020268861B2 (https=)
CA (1) CA3138719A1 (https=)
GB (3) GB2626699B (https=)
IL (1) IL287597A (https=)
MY (1) MY203765A (https=)
SG (1) SG11202112221TA (https=)
TW (1) TWI873135B (https=)
WO (1) WO2020225551A1 (https=)
ZA (1) ZA202109658B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202302862A (zh) * 2021-03-04 2023-01-16 英商牛津生物力學公眾有限公司 染色體交互作用標記物
WO2025215190A1 (en) * 2024-04-12 2025-10-16 Oxford BioDynamics PLC Method of typing chromosome markers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008323649A1 (en) * 2007-11-08 2009-05-14 University Of Washington DNA microarray based identification and mapping of balanced translocation breakpoints
US10364469B2 (en) * 2014-01-16 2019-07-30 Illumina, Inc Gene expression panel for prognosis of prostate cancer recurrence
JP6745820B2 (ja) * 2015-05-29 2020-08-26 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 前立腺がん予後判定の方法
JP2018527016A (ja) * 2015-06-24 2018-09-20 オックスフォード バイオダイナミックス リミテッド 染色体相互作用の検出
EP3548633B1 (en) * 2016-12-01 2024-01-24 Oxford BioDynamics PLC Application of epigenetic chromsomal interactions in cancer diagnostics

Similar Documents

Publication Publication Date Title
JP2024032860A (ja) 腫瘍遺伝子変異量を腫瘍割合およびカバレッジによって調整するための方法およびシステム
AU2025283650A1 (en) Methods for cancer detection and monitoring by means of personalized detection of circulating tumor DNA
WO2017077499A1 (en) Biomarkers of squamous cell carcinoma of head and neck, prognostic markers of recurrence in squamous cell carcinoma of head and neck, and methods thereof
CN109971852A (zh) 检测染色体片段中的突变和倍性
EP2121988B1 (en) Prostate cancer survival and recurrence
EP4320618A2 (en) Cell-free dna sequence data analysis method to examine nucleosome protection and chromatin accessibility
JP7631400B2 (ja) 遺伝子調節
EP3802878A1 (en) Methods and systems for determining the cellular origin of cell-free nucleic acids
JP2025032205A (ja) 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー
JP2011525106A (ja) 瀰漫性ｂ大細胞型リンパ腫のマーカーおよびその使用方法
JP2022532108A5 (https=)
US20180051342A1 (en) Prostate cancer survival and recurrence
ES3029416T3 (en) Chromosome interaction markers
CN117795098A (zh) 染色体相互作用标志物